Ads
related to: sars-cov-2 virus treatment
Search results
Antibiotic neomycin may protect against the flu, COVID-19
Medical News Today· 5 hours agoViral respiratory infections are common and generally result in a few days of illness from which...
Optimal timing maximizes Paxlovid benefits for treating COVID-19
Medical Xpress· 3 days agoResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published ...
How B cells recognize new variants of SARS-CoV-2
Medical Xpress· 3 days agoThe team describes how this works in the European Journal of Immunology. During the corona pandemic, the vaccination against SARS...
Federal avian flu response kicks into gear
Politico· 5 hours ago“During November 2022–May 2023, among persons infected with SARS-CoV-2, sensitivity of rapid antigen tests was 47% compared with RT-PCR ...
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
Center for Infectious Disease Research and Policy· 2 days agoTaking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19...
Are Monoclonal Antibodies the Future of Long COVID Treatments?
Technology Networks· 4 days agoOne study published in PLOS Pathogens in 2022 found that long COVID patients had 100 times the...
COVID-19 virus disrupts protein production: Researcher discusses her recent findings
Phys.org· 2 days agoOne thing we do know: Following infection, it's critical that our cells make new proteins to defend against the virus. Writer Jenni Bozec recently spoke with Yerlici—who is ...
NIH RECOVER Makes Long COVID Data Easier to Access - Deidentified Data from Thousands of Adults with...
Sierra Sun Times· 7 hours agoDeidentified data from thousands of adults with long COVID are now available to researchers. April...
Immunologist receives biomedical research award | Cornell Chronicle
Cornell News Service· 2 days agoAshley Nelson, assistant professor of immunology research in the Department of Pediatrics at Weill...
Common Antibiotic Shows Promise in the Treatment of Respiratory Viral Infections
Technology Networks· 4 days agoA new, Yale-led study suggests that a range of respiratory viral infections — including COVID-19 and...